From Book News, Inc.
Six contributions from researchers working in Japan, China, the U.S., and the U.K. summarize current scientific findings about the phytochemistry, bioactive compounds, pharmacological benefits, and preparation of medicinal plants in the Magnolia genus. The two largest chapters survey plant secondary metabolites reported from each Magnolia species, classify the biological activities of Magnoliaceae species, review the effect of Saiboku-to on histamine-related functions, and describe the pharmacological characteristic of magnolol and honokiol. Other topics include the history and traditional medicinal uses of Magnolia bark, chemical methods for quality analysis, and the commercial cultivation of Magnolia plants.Copyright © 2004 Book News, Inc., Portland, OR
Book Description
The genus Magnolia consists of several medicinally important species most of which come from Far East Asia. Many species of this genus have traditionally been used in China and Japan to treat various illnesses from simple headaches to complicated cancer, and because of their versatility have more recently been incorporated into commercially successful medicine preparations. And with the revival of interest in herbal and oriental traditional medicines, many of these Magnolia-containing preparations have captured a significant proportion of the drug market in the Western countries. In recent years several studies have been performed with Magnolia species, resulting in the isolation of a number of bioactive compounds and discovery of new biological and pharmacological activities. This books deals with many aspects of the genus Magnolia detailing areas such as phytochemistry, pharmacology, toxicology, quality control and commercial significance. It will be a very useful reference for academics, researchers and those involved in Magnolia trade.
Book Info
Gunma Univ. School of Medicine, Gunma, Japan. Comprehensive text on the aspects of the genus Magnolia. Includes information on phytochemistry, pharmacology, toxicology, quality control, and commercial significance. For students and researchers.
About the Author
Satyajit Sarker is with The Robert Gordon University in the UK and Yuji Maruyama is with the Gunma University School of Medicine in Japan.
Magnolia: The Genus Magnolia, Vol. 28 FROM THE PUBLISHER
The genus Magnolia consists of several medicinally important species most of which come from Far East Asia. Many species of this genus have traditionally been used in China and Japan to treat various illnesses from simple headaches to complicated cancer, and because of their versatility have more recently been incorporated into commercially successful medicine preparations. And with the revival of interest in herbal and oriental traditional medicines, many of these Magnolia-containing preparations have captured a significant proportion of the drug market in the Western countries. In recent years several studies have been performed with Magnolia species, resulting in the isolation of a number of bioactive compounds and discovery of new biological and pharmacological activities.
This books deals with many aspects of the genus Magnolia detailing areas such as phytochemistry, pharmacology, toxicology, quality control and commercial significance. It will be a very useful refere
SYNOPSIS
Six contributions from researchers working in Japan, China, the U.S., and the U.K. summarize current scientific findings about the phytochemistry, bioactive compounds, pharmacological benefits, and preparation of medicinal plants in the Magnolia genus. The two largest chapters survey plant secondary metabolites reported from each Magnolia species, classify the biological activities of Magnoliaceae species, review the effect of Saiboku-to on histamine-related functions, and describe the pharmacological characteristic of magnolol and honokiol. Other topics include the history and traditional medicinal uses of Magnolia bark, chemical methods for quality analysis, and the commercial cultivation of Magnolia plants. Annotation ©2003 Book News, Inc., Portland, OR